Package 68180-801-36

Brand: lapatinib

Generic: lapatinib
NDC Package

Package Facts

Identity

Package NDC 68180-801-36
Digits Only 6818080136
Product NDC 68180-801
Product ID 68180-801_d331d11d-21f4-472c-82d9-3b03b582026a
Description

150 TABLET in 1 BOTTLE (68180-801-36)

Marketing

Marketing Status
Marketed Since 2020-09-29
Brand lapatinib
Generic lapatinib
Sample Package No

Linked Drug Pages (1)

Lapatinib ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d331d11d-21f4-472c-82d9-3b03b582026a", "openfda": {"upc": ["0368180801368"], "unii": ["G873GX646R"], "rxcui": ["672149"], "spl_set_id": ["50d0dd0c-7682-43d0-aa1b-ca26e9181aee"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 TABLET in 1 BOTTLE (68180-801-36)", "package_ndc": "68180-801-36", "marketing_start_date": "20200929"}], "brand_name": "Lapatinib", "product_id": "68180-801_d331d11d-21f4-472c-82d9-3b03b582026a", "dosage_form": "TABLET", "pharm_class": ["Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "68180-801", "generic_name": "lapatinib", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lapatinib", "active_ingredients": [{"name": "LAPATINIB DITOSYLATE", "strength": "250 mg/1"}], "application_number": "ANDA203007", "marketing_category": "ANDA", "marketing_start_date": "20200929", "listing_expiration_date": "20261231"}